{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:01:29Z","timestamp":1793995289662,"version":"4.8.0"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1018\/13"],"award-info":[{"award-number":["1018\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bone.2017.06.020","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T14:45:18Z","timestamp":1498574718000},"page":"102-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link"],"prefix":"10.1016","volume":"103","author":[{"given":"Rony","family":"Sapir-Koren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Livshits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.06.020_bb0005","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Cross","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0010","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/art.10897","article-title":"Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification","volume":"48","author":"Rasch","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/03009749709065712","article-title":"The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey","volume":"26","author":"Kvien","year":"1997","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0025","first-page":"144","article-title":"Nature reviews","volume":"8","author":"Willemze","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.bone.2017.06.020_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2014.11.028","article-title":"Cytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis","volume":"75","author":"Taneja","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2017.06.020_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2010.05.018","article-title":"Estrogens in rheumatoid arthritis; the immune system and bone","volume":"335","author":"Islander","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2017.06.020_bb0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/acr.22494","article-title":"For the canadian early arthritis cohort investigators. Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian early arthritis cohort","volume":"67","author":"Wong","year":"2015","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.2011.200059","article-title":"Early menopause is an independent predictor of rheumatoid arthritis","volume":"71","author":"Pikwer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0049-0172(03)00084-2","article-title":"Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women","volume":"33","author":"Merlino","year":"2003","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0055","series-title":"Rheumatoid Arthritis","volume":"24","author":"Harris","year":"1997"},{"key":"10.1016\/j.bone.2017.06.020_bb0060","doi-asserted-by":"crossref","first-page":"R837","DOI":"10.1186\/ar1753","article-title":"Osteoporosis in experimental postmenopausal polyarthritis: The relative contributions of estrogen deficiency and inflammation","volume":"7","author":"Jochems","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.2007.084707","article-title":"Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis","volume":"68","author":"Pikwer","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0070","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1002\/art.20621","article-title":"Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the nurses' health study","volume":"50","author":"Karlson","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0075","first-page":"207","article-title":"The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study","volume":"31","author":"Doran","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10654-015-0004-y","article-title":"Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study","volume":"30","author":"Orellana","year":"2015","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.bone.2017.06.020_bb0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/ker224","article-title":"PTPN22 R620W genotype_phenotype correlation analysis and gene_environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort","volume":"50","author":"Salliot","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.bone.2017.06.020_bb0090","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/ard.2009.111179","article-title":"Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and\/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort","volume":"69","author":"Salliot","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/13697130903025449","article-title":"The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus","volume":"12","author":"Holroyd","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.bone.2017.06.020_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/263625","article-title":"Cytokine-mediated bone destruction in rheumatoid arthritis","author":"Jung","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bone.2017.06.020_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/art.24551","article-title":"The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis","volume":"60","author":"Solomon","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00296-007-0323-8","article-title":"Association of bone mineral density and vertebral deformity in patients with rheumatoid arthritis","volume":"27","author":"Ba\u015fkan","year":"2007","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.62.7.617","article-title":"Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis","volume":"62","author":"Forsblad D'Elia","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0125","first-page":"2590","article-title":"Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2years in women","volume":"30","author":"Forslind","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.10996","article-title":"Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study","volume":"49","author":"Lodder","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO): European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","article-title":"National Osteoporosis Guideline Group: case finding for the management of osteoporosis with FRAX \u2014 assessment and intervention thresholds for the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0145","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/ard.2007.070839","article-title":"Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis","volume":"66","author":"Guler-Yuksel","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/35.4.309","article-title":"Bone mass measurement and bone metabolism in rheumatoid arthritis: a review","volume":"35","author":"Deodhar","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","article-title":"Generalised bone loss in patients with early rheumatoid arthritis","volume":"344","author":"Gough","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2017.06.020_bb0160","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0165","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-008-0576-x","article-title":"Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis","volume":"28","author":"Oelzner","year":"2008","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0170","first-page":"2582","article-title":"A multicenter cross sectional study on bone mineral density in rheumatoid arthritis","volume":"27","author":"Sinigaglia","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0175","first-page":"1020","article-title":"Rheumatoid arthritis: evidence for bone loss in premenopausal women","volume":"32","author":"Tourinho","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0180","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/ar761","article-title":"Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin like growth factor 1","volume":"5","author":"Forsblad D'Elia","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb0185","first-page":"1456","article-title":"Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis","volume":"30","author":"Forsblad D'Elia","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0190","first-page":"62","article-title":"Trabecular bone density in premenopausal rheumatoid arthritis patients","volume":"92","author":"Kalla","year":"2002","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.bone.2017.06.020_bb0195","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","article-title":"Biologic therapies and systemic bone loss in rheumatoid arthritis","volume":"12","author":"Dimitroulas","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb0200","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"Van Staa","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0205","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tem.2010.01.010","article-title":"What old means to bone","volume":"21","author":"Manolagas","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.020_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1759720X11430858","article-title":"Aging and bone loss: new insights for the clinician","volume":"4","author":"Demontiero","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"N.Y. Acad. Sci., Ann."},{"key":"10.1016\/j.bone.2017.06.020_bb0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.bone.2017.06.020_bb0230","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.06.020_bb0235","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11914-009-0023-2","article-title":"Proinflammatory cytokines and osteoporosis","volume":"7","author":"McLean","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2017.06.020_bb0240","first-page":"1","article-title":"Research on menopause in the 1990s. Report of a WHO scientific group","volume":"866","author":"World Health Organization scientific group","year":"1996","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.bone.2017.06.020_bb0245","doi-asserted-by":"crossref","first-page":"A430","DOI":"10.1016\/j.autrev.2011.11.006","article-title":"Menopause in patients with autoimmune diseases","volume":"11","author":"Sammaritano","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb0250","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00198-009-1018-7","article-title":"Immune changes in postmenopausal osteoporosis: the immunos study","volume":"21","author":"Breuil","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0255","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.bor.0000127824.42507.68","article-title":"Bone loss in inflammatory arthritis: mechanisms and treatment strategies","volume":"16","author":"Walsh","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0265","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2017.06.020_bb0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/BOR.0000000000000007","article-title":"Arthritis and bone loss: a hen and egg story","volume":"26","author":"Kleyer","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0275","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00198-013-2334-5","article-title":"Can bone loss in rheumatoid arthritis be prevented?","volume":"24","author":"Vis","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0280","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11926-012-0252-8","article-title":"Inflammatory rheumatic disorders and bone","volume":"14","author":"Bultink","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bone.2017.06.020_bb0285","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/ard.2008.105957","article-title":"High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis","volume":"68","author":"Ursum","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0290","first-page":"3441","article-title":"Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis","volume":"81","author":"Canalis","year":"1996","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.bone.2017.06.020_bb0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mce.2016.05.009","article-title":"Rheumatoid arthritis onset in postmenopausal women: Does the ACPA seropositive subset result from genetic effects, estrogen deficiency, skewed profile of CD4(+) T-cells, and their interactions?","volume":"431","author":"Sapir-Koren","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2017.06.020_bb0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.1500","article-title":"Role of T cells in ovariectomy induced bone loss \u2014 revisited","volume":"27","author":"Pacifici","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0305","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2008.02.017","article-title":"Estrogen deficiency increases osteoclastogenesis upregulating T cells activity: a key mechanism in osteoporosis","volume":"43","author":"D'Amelio","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb0310","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.emboj.7601984","article-title":"Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival","volume":"27","author":"Krum","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.06.020_bb0315","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.06.020_bb0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000098223","article-title":"Osteoimmunology","volume":"143","author":"Rauner","year":"2007","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0325","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.06.020_bb0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/cmi.2010.54","article-title":"Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro","volume":"8","author":"Luo","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0335","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress ostoclast formation. A new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0340","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0345","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1098\/rsif.2009.0282","article-title":"Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures","volume":"7","author":"McNamara","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.bone.2017.06.020_bb0350","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/154405910608500703","article-title":"Bone remodeling in post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000342426","article-title":"Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities","volume":"160","author":"Rauner","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0360","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000443531","article-title":"Upregulated cellular expression of IL-17 by CD4+ T-cells in osteoporotic postmenopausal women","volume":"68","author":"Zhao","year":"2016","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.bone.2017.06.020_bb0370","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0375","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/rheumatology\/kel045","article-title":"RANKL protein is expressed at the pannus\u2013bone interface at sites of articular bone erosion in rheumatoid arthritis","volume":"45","author":"Pettit","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.bone.2017.06.020_bb0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X12438080","article-title":"The role of RANK ligand\/osteoprotegerin in rheumatoid arthritis","volume":"4","author":"Geusens","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0385","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.06.020_bb0390","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","article-title":"New developments in osteoimmunology","volume":"8","author":"Takayanagi","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0395","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10875-009-9316-6","article-title":"Osteoimmunology: crosstalk between the immune and bone systems","volume":"29","author":"Nakashima","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0400","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0405","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2017.06.020_bb0410","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0415","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0420","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/art.22733","article-title":"Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified","volume":"56","author":"Miossec","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0425","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0430","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/erv.12.146","article-title":"T-cell-based immunotherapy of autoimmune diseases","volume":"12","author":"Ulivieri","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bone.2017.06.020_bb0435","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","article-title":"RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation","volume":"75","author":"Danks","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0440","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/art.23943","article-title":"OSCAR, a key co-stimulation molecule for osteoclasts, is induced in patients with rheumatoid arthritis","volume":"58","author":"Herman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0445","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2017.06.020_bb0450","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.21896","article-title":"The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction","volume":"54","author":"Geusens","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0455","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/40.6.623","article-title":"Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint","volume":"40","author":"Haynes","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bone.2017.06.020_bb0460","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0465","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/annrheumdis-2015-208052","volume":"75","author":"Takeuchi","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0470","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/eji.200838192","article-title":"IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kb (RANK) expression in myeloid precursor cells","volume":"38","author":"Li","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0475","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","article-title":"Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo","volume":"60","author":"Axmann","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0480","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bone.2004.07.004","article-title":"TNF-\u03b1 antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis","volume":"35","author":"Saidenberg-Kermanac'h","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb0485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/ar2879","article-title":"RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNF\u03b1 or anti-IL-1 therapies","volume":"11","author":"Stolina","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb0490","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nm.2007","article-title":"Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis","volume":"15","author":"Zhao","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0495","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7150\/ijms.5180","article-title":"Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective","volume":"9","author":"Zhao","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bone.2017.06.020_bb0500","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.06.020_bb0505","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","article-title":"Changes in proinflammatory cytokine activity after menopause","volume":"23","author":"Pfeilschifter","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb0510","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1074\/jbc.M112.426080","article-title":"Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-kappaB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity","volume":"288","author":"Furuya","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.06.020_bb0515","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI0215687","article-title":"Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency","volume":"110","author":"Weitzmann","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0520","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bone.2017.06.020_bb0525","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice","volume":"1997","author":"Kimble","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0530","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.070409","article-title":"Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study","volume":"22","author":"Cauley","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0535","doi-asserted-by":"crossref","first-page":"429713","DOI":"10.1155\/2015\/429713","article-title":"Endogenous estrogen-mediated heme oxygenase regulation in experimental menopause","volume":"2015","author":"P\u00f3sa","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bone.2017.06.020_bb0540","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/GME.0000000000000125","article-title":"A high prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency","volume":"21","author":"Moln\u00e1r","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.bone.2017.06.020_bb0545","doi-asserted-by":"crossref","first-page":"e44552","DOI":"10.1371\/journal.pone.0044552","article-title":"Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis","volume":"7","author":"Tyagi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.06.020_bb0550","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.maturitas.2010.08.003","article-title":"Menopause and aging: changes in the immune system \u2014 a review","volume":"67","author":"Gameiro","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.bone.2017.06.020_bb0555","doi-asserted-by":"crossref","first-page":"3580e3589","DOI":"10.1096\/fj.10-160911","article-title":"Gender specificity of altered human immune cytokine profiles in aging","volume":"24","author":"Goetzl","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2017.06.020_bb0560","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1720387","article-title":"Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of post-menopausal women","volume":"172","author":"Rachon","year":"2002","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2017.06.020_bb0565","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/art.11150","article-title":"Osteoproteogerin protects against generalized bone loss in tumor necrosis factor transgenic mice","volume":"48","author":"Schett","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0570","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.06.020_bb0575","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1096\/fj.04-2214fje","article-title":"Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis","volume":"19","author":"D'Amelio","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2017.06.020_bb0580","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.0105-2896.2005.00324.x","article-title":"The role of T lymphocytes in bone metabolism","volume":"208","author":"Weitzmann","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb0585","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligang","volume":"106","author":"Lam","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0590","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.intimp.2012.12.010","article-title":"Synergistic effects of interleukin-1\u03b2 and interleukin-17A antibodies on collagen induced arthritis mouse model","volume":"15","author":"Zhang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bone.2017.06.020_bb0595","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cyto.2005.11.005","article-title":"The combined effects of anti-TNF\u03b1 antibody and IL-1 receptor antagonist in human rheumatoid arthritis synovial membrane","volume":"32","author":"Hosaka","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2017.06.020_bb0600","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/14622416.6.5.481","article-title":"Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis","volume":"6","author":"Ranganathan","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bone.2017.06.020_bb0605","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0610","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/ard.2005.044198","article-title":"Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis","volume":"65","author":"Vis","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0615","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF down modulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bone.2017.06.020_bb0620","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/annrheumdis-2011-201024","article-title":"Incomplete response of inflammatory arthritis to blockade is associated with the Th17 pathway","volume":"71","author":"Alzabin","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0625","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0630","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2310\/JIM.0b013e3181eb9895","article-title":"Infliximab reduces the frequency of interleukin 17-producing cells and the amounts of interleukin 17 in patients with rheumatoid arthritis","volume":"58","author":"Shen","year":"2010","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0635","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells","volume":"88","author":"Pacifici","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.06.020_bb0640","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0645","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","article-title":"Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study","volume":"93","author":"Ding","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.020_bb0650","first-page":"2032","article-title":"Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause","volume":"86","author":"Scheidt-Nave","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.020_bb0655","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5122(96)01080-8","article-title":"Increase in cytokine production (IL-1 beta, IL-6, TNFalpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis","volume":"26","author":"Zheng","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.bone.2017.06.020_bb0660","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI118432","article-title":"Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal\/osteoblastic cells","volume":"97","author":"Bellido","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0665","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion","volume":"13","author":"Poli","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.06.020_bb0670","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1359\/jbmr.1998.13.3.393","article-title":"IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures","volume":"13","author":"Devlin","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0675","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.144.11.4226","article-title":"IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release","volume":"144","author":"Kurihara","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0680","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1359\/jbmr.2000.15.8.1545","article-title":"Cytokines and bone loss in a five-year longitudinal study \u2014 HRT suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist","volume":"15","author":"Abrahamsen","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0685","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.1998.4320","article-title":"Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells","volume":"247","author":"Jimi","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0690","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0695","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.2008.104786","article-title":"Interleudin-1 is essential for systemic inflammatory bone loss","volume":"69","author":"Polzer","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0700","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1359\/jbmr.070207","article-title":"Effect of blockade of TNF-\u03b1 and interleukin-1 action on bone resorption in early postmenopausal women","volume":"22","author":"Charactcharoenwitthaya","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0705","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.06.020_bb0710","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.06.020_bb0715","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.10.006","article-title":"The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy","volume":"74","author":"Roeleveld","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2017.06.020_bb0720","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0725","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ni1391","article-title":"Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease","volume":"7","author":"Veldhoen","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0730","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0735","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ni.2947","article-title":"TGF-\u03b2 co-opts STAT3-STAT4 signaling to promote human T follicular helper cell differentiation","volume":"15","author":"Schmitt","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0740","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","article-title":"Follicular helper T cells in immunity and systemic autoimmunity","volume":"8","author":"Craft","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0745","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.4049\/jimmunol.165.6.3423","article-title":"Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium","volume":"165","author":"Buckley","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0750","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/09513590.2014.975683","article-title":"Changes of serum cytokines-related Th1\/Th2\/Th17 concentration in patients with postmenopausal osteoporosis","volume":"31","author":"Zhang","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.bone.2017.06.020_bb0755","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00198-013-2548-6","article-title":"IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis","volume":"25","author":"Moln\u00e1r","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb0760","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/jcb.24165","article-title":"IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner","volume":"113","author":"DeSelm","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2017.06.020_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018168","article-title":"Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo\/JngJ mice","volume":"6","author":"Won","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.06.020_bb0770","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/eci.12158","article-title":"Immune regulation of bone loss by Th17 cells in oestrogen-deficient osteoporosis","volume":"43","author":"Zhao","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bone.2017.06.020_bb0775","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jbmr.2228","article-title":"Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-\u03b1 antibodies","volume":"29","author":"Tyagi","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0780","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","article-title":"Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23","volume":"191","author":"Paulissen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0785","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0790","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2007.09.014","article-title":"IL-17\/Th17 targeting: on the road to prevent chronic destructive arthritis?","volume":"41","author":"Lubberts","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2017.06.020_bb0795","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13075-015-0740-0","article-title":"Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis","volume":"17","author":"Mangnus","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb0800","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.semarthrit.2008.10.008","article-title":"Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis","volume":"39","author":"Daoussis","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0805","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0810","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/BOR.0000000000000036","article-title":"T cell subsets and their role in the pathogenesis of rheumatic disease","volume":"26","author":"Gizinski","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0815","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20110496","article-title":"IL-17\/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential","volume":"122","author":"Zhu","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bone.2017.06.020_bb0820","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00018-003-3228-z","article-title":"Interleukin-17: a mediator of inflammatory responses","volume":"61","author":"Witowski","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bone.2017.06.020_bb0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026342","article-title":"IL17RA signaling amplifies antibody-induced arthritis","volume":"6","author":"Sadik","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.06.020_bb0830","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0835","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb0840","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13075-015-0548-y","article-title":"Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis","volume":"17","author":"Andersson","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb0845","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial","volume":"67","author":"Emery","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0850","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(09)60506-7","article-title":"GO-AFTER study investigators. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial","volume":"374","author":"Smolen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2017.06.020_bb0855","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb0860","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3899\/jrheum.140831","article-title":"Safety and efficacy of open-label subcutaneous Ixekizumab treatment for 48weeks in a phase II study in biologic-naive and TNF-IR patients with rheumatoid arthritis","volume":"43","author":"Genovese","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0865","doi-asserted-by":"crossref","first-page":"33680","DOI":"10.1038\/srep33680","article-title":"IL-18BP is decreased in osteoporotic women: prevents inflammasome mediated IL-18 activation and reduces Th17 differentiation","volume":"6","author":"Mansoori","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bone.2017.06.020_bb0870","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10753-012-9524-8","article-title":"IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis","volume":"36","author":"Zhang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.bone.2017.06.020_bb0875","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.170.4.2100","article-title":"Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein","volume":"170","author":"Banda","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb0880","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.06.020_bb0885","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.archoralbio.2014.05.009","article-title":"IL-17 inhibits osteoblast differentiation and bone regeneration in rat","volume":"59","author":"Kim","year":"2014","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bone.2017.06.020_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","article-title":"Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology","volume":"321","author":"Nanes","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.bone.2017.06.020_bb0895","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jbmr.5650020612","article-title":"Interleukin-1 beta is a potent inhibitor of bone formation in vitro","volume":"2","author":"Stashenko","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0900","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"OB function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24","author":"Walsh","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0905","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI1039","article-title":"Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption","volume":"101","author":"Jilka","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0910","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2011-201075","article-title":"Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study","volume":"72","author":"Finzel","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0915","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2010.148395","article-title":"Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion","volume":"70","author":"Finzel","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb0920","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.rdc.2010.03.003","article-title":"Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention","volume":"36","author":"Karmakar","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.bone.2017.06.020_bb0925","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-a-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0930","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.06.020_bb0935","doi-asserted-by":"crossref","first-page":"23084","DOI":"10.1074\/jbc.M709848200","article-title":"Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins","volume":"283","author":"Guo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.06.020_bb0940","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6793-7-13","article-title":"An extensive phenotypic characterization of the hTNF\u03b1 transgenic mice","volume":"7","author":"Hayward","year":"2007","journal-title":"BMC Physiol."},{"key":"10.1016\/j.bone.2017.06.020_bb0945","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI38716","article-title":"NF-\u03baB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism","volume":"119","author":"Yao","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","article-title":"Update on Wnt signaling in bone cell biology and bone disease","volume":"492","author":"Monroe","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bone.2017.06.020_bb0955","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2015.05.025","article-title":"Bone morphogenetic protein signaling in bone homeostasis","volume":"80","author":"Sanchez-Duffhues","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb0960","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/me.2011-1168","article-title":"BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b","volume":"26","author":"Kokabu","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2017.06.020_bb0965","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/83810","article-title":"Bone morphogenetic protein-3 is a negativeregulator of bone density","volume":"27","author":"Daluiski","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.06.020_bb0970","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/03009742.2015.1126347","article-title":"Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation","volume":"45","author":"Matzelle","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb0975","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S8756-3282(97)00038-0","article-title":"Interleukin-1 beta enhances and tumor necrosis factor alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells","volume":"21","author":"Nakase","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb0980","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/03008200903019703","article-title":"TNF-alpha upregulates expression of BMP-2 and BMP-3 genes in the rat dental follicle\u2013implications for tooth eruption","volume":"51","author":"Yao","year":"2010","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.bone.2017.06.020_bb0985","doi-asserted-by":"crossref","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","article-title":"Glucocorticoids and tumor necrosis factor \u03b1 increase oxidative stress and suppressWnt protein signaling in osteoblasts","volume":"286","author":"Almeida","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.06.020_bb0990","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb0995","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","article-title":"Rheumatic diseases: the effects of inflammation on bone","volume":"208","author":"Walsh","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb1000","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","article-title":"The Wnt signaling pathway in development and disease","volume":"20","author":"Logan","year":"2004","journal-title":"Annu. Rev. l Dev. Biol."},{"key":"10.1016\/j.bone.2017.06.020_bb1005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.bone.2017.06.020_bb1010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","article-title":"Bone remodeling in rheumatic disease: a question of balance","volume":"233","author":"Walsh","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bone.2017.06.020_bb1015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of osteoporosis: a mini-review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology"},{"key":"10.1016\/j.bone.2017.06.020_bb1020","first-page":"77","article-title":"In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density","volume":"33","author":"Rossini","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3899\/jrheum.100089","article-title":"Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis","volume":"38","author":"Wang","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1030","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bone.2017.06.020_bb1035","first-page":"817","article-title":"Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis","volume":"27","author":"De Rooy","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb1040","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/art.39183","article-title":"Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint","volume":"67","author":"Yeremenko","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1196\/annals.1351.040","article-title":"Bone metabolism changes during anti-TNF-\u03b1 therapy in patients with active rheumatoid arthritis","volume":"1069","author":"Seriolo","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2017.06.020_bb1050","doi-asserted-by":"crossref","DOI":"10.1186\/ar2297","article-title":"IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats","volume":"9","author":"Yago","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1055","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/ar3070","article-title":"Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins","volume":"12","author":"Van Steendam","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1060","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar1926","article-title":"Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells","volume":"8","author":"Mathsson","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1065","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar2478","article-title":"Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis","volume":"10","author":"Zhao","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1070","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1002\/eji.201344424","article-title":"DRB1\u20440402 may influence arthritis by promoting naive CD4 T-cell differentiation in to regulatory T cells","volume":"44","author":"Luckey","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bone.2017.06.020_bb1075","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","article-title":"Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies","volume":"73","author":"Kleyer","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb1080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/ard.2010.139527","article-title":"Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase","volume":"70","author":"Van de Sande","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb1085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11914-013-0185-9","article-title":"Autoantibody mediated bone loss","volume":"12","author":"Harre","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2017.06.020_bb1090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13075-016-1116-9","article-title":"Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis","volume":"18","author":"Bugatti","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1095","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb1105","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb1110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb1115","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20072051","article-title":"The arthritogenicity of human anti-citrullinated peptide antibodies in rheumatoid arthritis (RA)","volume":"205","author":"Hill","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb1120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.20051951","article-title":"Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB","volume":"203","author":"Petkova","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb1125","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb1130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13075-015-0760-9","article-title":"Serum RANKL levels associate with anti-citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate","volume":"17","author":"Hensvold","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1135","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/art.27386","article-title":"Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte\/macrophages and stimulate tumor necrosis factor alpha production","volume":"62","author":"Lu","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb1140","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.06.020_bb1145","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1038\/ncomms7651","article-title":"Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss","volume":"6","author":"Harre","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2017.06.020_bb1150","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1073\/pnas.1301001110","article-title":"Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice","volume":"110","author":"Seeling","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.06.020_bb1155","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.bone.2017.06.020_bb1160","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3899\/jrheum.151253","article-title":"Interleukin 34 upregulation contributes to the increment of MicroRNA 21 expression through STAT3 activation associated with disease activity in rheumatoid arthritis","volume":"43","author":"Yang","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1165","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/jcmm.12353","article-title":"Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis","volume":"18","author":"Dong","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb1170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/annrheumdis-2011-200096","article-title":"Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients","volume":"71","author":"Chemel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.06.020_bb1175","first-page":"7809","article-title":"Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb1180","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3892\/mmr.2014.2353","article-title":"Tumor necrosis factor-\u03b1 induces interleukin-34 expression through nuclear factor-\u03baB activation in MC3T3-E1 osteoblastic cells","volume":"10","author":"Yu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bone.2017.06.020_bb1185","article-title":"The critical role of IL-34 in osteoclastogenesis","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.06.020_bb1190","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3899\/jrheum.130356","article-title":"Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis","volume":"40","author":"Moon","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1195","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/jir.2012.0122","article-title":"Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production","volume":"33","author":"Tian","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.bone.2017.06.020_bb1200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2013.12.002","article-title":"A myostatin and activin decoy receptor enhances bone formation in mice","volume":"60","author":"Bialek","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb1205","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bone.2007.02.012","article-title":"Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading","volume":"40","author":"Hamrick","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.020_bb1210","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm.3917","article-title":"Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice","volume":"21","author":"Dankbar","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.06.020_bb1215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.020_bb1220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11914-009-0005-4","article-title":"Glucocorticoid-induced osteoporosis","volume":"7","author":"Silverman","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2017.06.020_bb1225","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroidinduced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.020_bb1230","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.06.020_bb1235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar4180","article-title":"Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy","volume":"15","author":"Aeberli","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2017.06.020_bb1240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrrheum.2009.259","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"6","author":"Compston","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1245","first-page":"1895","article-title":"Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids","volume":"19","author":"Montecucco","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10067-007-0747-2","article-title":"Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?","volume":"27","author":"Korczowska","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bone.2017.06.020_bb1255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2169\/internalmedicine.56.7797","article-title":"Effects of Denosumab on bone metabolic markers and bone mineral density in patients treated with glucocorticoids","volume":"56","author":"Sawamura","year":"2017","journal-title":"Intern. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:41:29Z","timestamp":1757612489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217302193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":251,"alternative-id":["S8756328217302193"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.06.020","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}